Evidence for the role of endogenous Ang II within the NTS, particularly in cardiovascular disease, or conditions of high sympathetic drive comes from a series of experiments where AT1R antagonists are injected into the NTS of rats with atriovenous (A–V) shunts. Here, AGT is linked to cardiovascular disorder.